In an exhaustive treatise Walford has proposed an immunologic theory of aging which he claims provides a link between etiologic theories and actual aging in higher animals. We have re-examined the relationships between various aspects of the aging process and the functional state of the immune system and have classified aging into primary and secondary events. Primary aging would be that period of chronological aging during which there is a genetically programmed decline in functional effectiveness which is either associated with or controlled by the immune system. Either the thymus acts as a biological clock which is genetically programmed to operate at a rate consistent with the optimal life time of the species adhering to the Hayflick limit or the T cell maturation process decays subsequent to functional exhaustion of cells, most likely, but not necessarily residing in the thymus, which elaborate factors necessary for T cell maturation and function. All other concomitants of aging are classified as secondary aging events. These events would encompass pathology and disease processes commonly associated with aging but which have not been shown to have a direct causal relationship.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.